An Israeli health startup claims to predict which diabetes patients will develop renal dysfunction within a one -year time frame using solutions based on automatic artificial intelligence learning.
Medial EarlySign announced on Monday the conclusion of a clinical data study based on an algorithm developed by the KFAR Malal company that was able to identify patients at risk through the analysis of electronic health records that include laboratory exam results, demographic data,Medications and diagnostic codes.
"By isolating less than 5 percent of the population of 400,000 diabetics selected between the company's database of 15 million patients, the algorithm could identify 45% of patients who would progress to significant renal damage within a year,Before becoming symptomatic.
The medial director of Medial EarlySign, Dr. Ran Goshen, said: Great efforts were invested in the development of treatment protocols to reduce the number of patients who will develop renal dysfunction due to diabetes. The EarlySign medial algorithm can helpThose responsible for decision -making, drug developers, insurers and suppliers to better assign their limited resources and ensure a preferential clinical result also.ESRD) ".
Renal disease, or nephropathy and other kidney problems are a serious complication caused by type 1 diabetes and type 2. Diabetes is also one of the main causes of renal failure and up to 40 percent of diabetics eventually develop kidney disease, according toThe Mayo Clinic.Approximately 400 million people worldwide suffer from diabetes, according to the 2014 figures published by the World Health Organization (WHO).It is estimated that more than 1.5 million deaths were caused directly by the disease, according to WHO.
